Early experience of maintenance durvalumab post chemoradiation (CRT) in stage III non-small cell lung cancer (NSCLC) across West Yorkshire network: from Expanded Access Programme (EAP) to routine clinical use

Lung Cancer ◽  
2020 ◽  
Vol 139 ◽  
pp. S46 ◽  
Author(s):  
P. Jain ◽  
P. Murray ◽  
K. Clarke ◽  
K. Franks ◽  
M. Teo ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Early Experience ◽  
Small Cell ◽  
Stage Iii ◽  
Clinical Use ◽  
Small Cell Lung ◽  
Expanded Access Programme ◽  
Access Programme

scholarly journals Erlotinib in salvage treatment of patients with advanced non-small cell lung cancer: results of an expanded access programme in Poland

2012 ◽  
Vol 2 ◽  
pp. 170-175
Author(s):  
Dariusz M. Kowalski ◽  
Maciej Krzakowski ◽  
Rodryg Ramlau ◽  
Piotr Jaskiewicz ◽  
Anna Janowicz-Żebrowska
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Salvage Treatment ◽  
Small Cell ◽  
Small Cell Lung ◽  
Expanded Access ◽  
Expanded Access Programme ◽  
Access Programme
Sign in / Sign up

Export Citation Format

Share Document